Potencjał terapeutyczny wybranych substancji psychoaktywnych — przegląd najnowszych badań
Psychiatria June 5, 2024 Anna Stankiewicz, Jan Szewczyk, Julia Truszkowska et al. 1 citation
Since 2019, research on psychedelics including LSD, MDMA, psilocybin, and THC, as well as less-studied substances like 5-MeO-DMT, dextromethorphan, DMT, ibogaine, ketamine, and mescaline, indicates therapeutic potential for treating addiction (nicotine, alcohol, and substance dependence), depression, anxiety (including anxiety in autism spectrum disorder), PTSD, and eating disorders. With appropriate protocols, these psychoactive agents may become part of comprehensive therapy for mental disorders.